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Introduction
Surgery-related bleeding is an issue in congenital bleeding disorders and little is known about “minor surgical
interventions” (endoscopy with biopsies, arthroscopic surgery, lymph node biopsies, skin or breast biopsies, and
complicated dental work) as defined by Kitchens (1) .
Methods:
Thirty-eight such procedures were performed in 34 FVII-deficient patients within the frame of the STER, a prospective
treatment registry (2), TAB.1. Replacement schedules were the choice of the physician in charge. Baseline FVIIc
ranged: <1-20%. Reported interventions were: Oral Surgery and multiple dental extractions (n=8), single dental
extractions (n=7), ENT and Head & Neck (n=5), catheter insertions (n=3), endoscopic biopsies (n=7) and mixed
interventions (n=8). Replacement therapy (RT) resulted as follows: rFVIIa employed in 29 pt., pdFVII in 8 and FFP in 1.
Antifibrinolytics were used in16 pt. (in oral surgery: 11/16).
Results:
Overall, RT was given for one day in 27 procedures,
employed namely in endoscopic biopsies (7/7), catheter
insertions (3/3) and single dental extractions (7/7), TAB.2. In
the remaining interventions (n=11, i.e. multiple dental
extractions, tonsillectomies) RT was given for 2-10 days.
Total rFVIIa dose ranged: 7.2-400 µg/Kg bw; total pFVII
range: 9-300 IU/Kg. No bleeding or thrombotic events were
recorded. In one patient, heavily treated with different RT,
an inhibitor to FVII (max titre: 28 BU) appeared four weeks
after the procedure.
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Conclusion
For most of the uncomplicated minor
surgery procedures, one-day RT is
sufficient with low to intermediate
doses of rFVIIa (15 - 60 µg/Kg/bw). In
complicated and elaborated
interventions longer lasting RT
schedules may be needed.
Males Females
n (%)
symptomatic 
(%)
n (%)
symptomatic 
(%)
All        n=34
11 3 23 20
(32.3) (27.3) (67.6) (86.9)
FVIIc levels 
(%)
≤1
0 0 9 8
(0.0) (0.0) (39.1) (88.9)
>1–10
5 1 9 9
(45.5) (20.0) (39.1) (100.0)
>10–20
6 2 5 2
(54.5) (33.3) (21.7) (40.0)
Minor Surgery 
Procedures
n
Replacement 
Therapy (RT)
RT 
days
Total n. 
of
doses
Total dose
µg/Kg     IU/Kg
Anti-
Fibrino-
lytics
Adverse
events
Oral Surgery  
+ Multiple 
extractions
8
rFVIIa     7
pdFVII    1 1 - 4 2 - 10
rFVIIa 19 – 60
pdFVII   1.3
5/8 Inhibitor (1 case)
Single 
extractions
7
rFVIIa     6
pdFVII    1
1 1 - 2
rFVIIa  14 – 110
pdFVII    300
6/7 NO
ENT and Head 
& Neck
5
rFVIIa     4
pdFVII    1
1 - 10 1 - 16
rFVIIa  7.2 - 400
pdFVII    112
2/5 NO
Catheters 3
pdFVII    2
FFP         1
1 1 - 4
pdFVII 18 – 29
FFP     50 ml/Kg
NO NO
Endoscopies 7 rFVIIa     7 1 1 - 7 rFVIIa  10 - 300 2/7 NO
Mixed 8
rFVIIa     5
pdFVII    3
1 - 9 1 - 16
rFVIIa   15 - 60
pdFVII  60 - 370
1/8 NO
TAB.1: GENERAL DATA                                                           TAB.2  MINOR SURGCAL PROCEDURES AND TREATMENT SCHEDULES
